+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study



Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study



Journal of Antimicrobial ChemoTherapy 12(4): 371-376



The hypothesis that the pharmacokinetics of amikacin are more predictable than those of gentamicin or tobramycin was studied. In a three-way crossover design 58 volunteers received 7.5 mg/kg amikacin by iv infusion and either 1.5 mg/kg or 1 mg/kg gentamicin and tobramycin. The mean half-life and mean serum concentration at 1 h for each drug was determined. No consistent significant difference was found between the pharmacokinetics of amikacin and the other two drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 044207301

Download citation: RISBibTeXText

PMID: 6643332

DOI: 10.1093/jac/12.4.371


Related references

Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin. Journal of Infectious Diseases 134 Suppl: S200-S205, 1976

Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin. European Journal of Clinical Pharmacology 24(5): 639-642, 1983

Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin. La Nouvelle Presse Medicale 11(46): 3419-3425, 1982

A comparative study of the population pharmacokinetics of gentamicin and amikacin in newborn patients. Journal Of Clinical Pharmacy & Therapeutics. 18(6): 411-413, 1993

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Antimicrobial Agents and ChemoTherapy 18(2): 338-345, 1980

Pharmacokinetics and safety of tobramycin nebulization with the I-nebĀ® and PARI-LC PlusĀ® in children with cystic fibrosis: a randomized, crossover study. British Journal of Clinical Pharmacology 2019, 2019

Compatibility of ceftazidime arginine with high dose gentamicin , tobramycin , or amikacin and low dose amikacin. Pharmacotherapy 16(1): 131, 1996

Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin. Antimicrobial Agents and ChemoTherapy 18(1): 176-181, 1980

Comparative oto toxicity of tobramycin gentamicin amikacin and sisomicin. Siegenthaler, Walter And Ruedi Luethy (Ed ) Current Chemotherapy Proceedings Of The 10th International Congress Of Chemotherapy, Vols I And Ii Zurich, Switzerland, Sept 18-23, 1977 Xxiv+736p (Vol I); 625p (Vol Ii) Illus American Society For Microbiology: Washington, D C , Usa ISBN 0-914826-16-6: 939-941, 1978

Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig. Journal of Antimicrobial ChemoTherapy 4 Suppl A: 73-83, 1978

Stability of amikacin, gentamicin, or tobramycin in 10% dextrose injection. American Journal of Hospital Pharmacy 51(4): 518-519, 1994

In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrobial Agents and ChemoTherapy 11(1): 64-73, 1977

The in vitro activity of netromycin in comparison with gentamicin tobramycin and amikacin. Zhongguo Kanfshengsu Zazhi 12(6): 411-416, 1987

Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig. Proceedings of the Western Pharmacology Society 20: 449-453, 1977

The stability of amikacin gentamicin and tobramycin in total nutrient admixtures. Journal Of Parenteral & Enteral Nutritionsuppl: 6s, 1987